杭州德适生物科技有限公司位于浙江省杭州市余杭区仓前街道龙泉路22号恒生电商产业园2号楼318室, 杭州市, 浙江省,中国。
We're tracking 杭州德适生物科技有限公司's market expansion
How 杭州德适生物科技有限公司's international expansion compares to its competitors
杭州德适生物科技有限公司YouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 杭州德适生物科技有限公司You | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Diagens, a medical imaging AI company, goes public on HKEX, raising $101 million with shares up 104.65% on first day.
Polycystic Ovary Syndrome renamed to Polyendocrine Metabolic-Ovarian Syndrome (PMOS) in May 2026, reclassified as systemic metabolic disease affecting 170 million women globally.
Hangzhou Diagens Biotech achieved RMB 164 million revenue, up 133.7% year-on-year, driven by its iMedImage® foundation model. Technology licensing revenue surged 331.7% to RMB 84.34 million with 71.8% gross margin.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about 杭州德适生物科技有限公司's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
